Phase 1 Study of KH607 Tablets
Clinical trial NCT06393803 · UNKNOWN
Trial details
- NCT number
- NCT06393803
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-21
- Primary completion
- 2024-10-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.